{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T21:32:02Z","timestamp":1793309522753,"version":"4.5.0"},"reference-count":191,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2008,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Many different drugs and agents may cause nephrotoxic acute kidney injury (AKI) in children. Predisposing factors such as age, pharmacogenetics, underlying disease, the dosage of the toxin, and concomitant medication determine and influence the severity of nephrotoxic insult. In childhood AKI, incidence, prevalence, and etiology are not well defined. Pediatric retrospective studies have reported incidences of AKI in pediatric intensive care units (PICU) of between 8% and 30%. It is widely recognized that neonates have higher rates of AKI, especially following cardiac surgery, severe asphyxia, or premature birth. The only two prospective studies in children found incidence rates of 4.5% and 2.5% of AKI in children admitted to PICU, respectively. Nephrotoxic drugs account for about 16% of all AKIs most commonly associated with AKI in older children and adolescents. Nonsteroidal anti-inflammatory drugs (NSAIDs), antibiotics, amphotericin B, antiviral agents, angiotensin-converting enzyme (ACE) inhibitors, calcineurin inhibitors, radiocontrast media, and cytostatics are the most important drugs to indicate AKI as significant risk factor in children. Direct pathophysiological mechanisms of nephrotoxicity include constriction of intrarenal vessels, acute tubular necrosis, acute interstitial nephritis, and\u2014more infrequently\u2014tubular obstruction. Furthermore, AKI may also be caused indirectly by rhabdomyolysis. Frequent therapeutic measures consist of avoiding dehydration and concomitant nephrotoxic medication, especially in children with preexisting impaired renal function.<\/jats:p>","DOI":"10.1007\/s00467-007-0721-x","type":"journal-article","created":{"date-parts":[[2008,1,28]],"date-time":"2008-01-28T10:03:43Z","timestamp":1201514623000},"page":"2159-2173","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":116,"title":["Nephrotoxicity as a cause of acute kidney injury in children"],"prefix":"10.1007","volume":"23","author":[{"given":"Ludwig","family":"Patzer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,12,1]]},"reference":[{"key":"721_CR1","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1586\/14737140.7.2.233","volume":"7","author":"B Coiffier","year":"2007","unstructured":"Coiffier B, Riouffol C (2007) Management of tumor lysis syndrome in adults. Expert Rev Anticancer Ther 7:233\u2013239","journal-title":"Expert Rev Anticancer Ther"},{"key":"721_CR2","first-page":"13","volume":"1","author":"Y Bertrand","year":"2005","unstructured":"Bertrand Y (2005) Recommendations of the French Society for the Control of Cancers and Leukemias in Children for the treatment of tumor lysis syndrome: results of a pediatric survey. Arch Pediatr 12 1:13\u201315","journal-title":"Arch Pediatr 12"},{"key":"721_CR3","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.amjmed.2003.09.045","volume":"116","author":"MB Davidson","year":"2004","unstructured":"Davidson MB, Thakkar S, Hix JK, Bhandarkar ND, Wong A, Schreiber MJ (2004) Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome. Am J Med 116:546\u2013554","journal-title":"Am J Med"},{"key":"721_CR4","first-page":"13","volume":"38","author":"CH Pui","year":"2001","unstructured":"Pui CH (2001) Urate oxidase in the prophylaxis or treatment of hyperuricemia: the United States experience. Semin Hematol 38:13\u201321","journal-title":"Semin Hematol"},{"key":"721_CR5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF02893442","volume":"13","author":"I Renyi","year":"2007","unstructured":"Renyi I, Bardi E, Udvardi E, Kovacs G, Bartyik K, Kajtar P, Masat P, Nagy K, Galantai I, Kiss C (2007) Prevention and treatment of hyperuricemia with rasburicase in children with leukemia and non-Hodgkin\u2019s lymphoma. Pathol Oncol Res 13:57\u201362","journal-title":"Pathol Oncol Res"},{"key":"721_CR6","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1182\/blood.V97.10.2998","volume":"97","author":"SC Goldman","year":"2001","unstructured":"Goldman SC, Holcenberg JS, Finklestein JZ, Hutchinson R, Kreissman S, Johnson FL, Tou C, Harvey E, Morris E, Cairo MS (2001) A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis. Blood 97:2998\u20133003","journal-title":"Blood"},{"key":"721_CR7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00280-002-0556-x","volume":"51","author":"L Baeksgaard","year":"2003","unstructured":"Baeksgaard L, Sorensen JB (2003) Acute tumor lysis syndrome in solid tumors\u2013a case report and review of the literature. Cancer Chemother Pharmacol 51:187\u2013192","journal-title":"Cancer Chemother Pharmacol"},{"key":"721_CR8","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2165\/00148581-200709030-00005","volume":"9","author":"G Filler","year":"2007","unstructured":"Filler G (2007) Calcineurin inhibitors in pediatric renal transplant recipients. Paediatr Drugs 9:165\u2013174","journal-title":"Paediatr Drugs"},{"key":"721_CR9","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1097\/01.ASN.0000079042.13465.1A","volume":"14","author":"RL Mehta","year":"2003","unstructured":"Mehta RL, Chertow GM (2003) Acute renal failure definitions and classification: time for change? J Am Soc Nephrol 14:2178\u20132187","journal-title":"J Am Soc Nephrol"},{"key":"721_CR10","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1200\/JCO.1988.6.10.1562","volume":"6","author":"SI Bearman","year":"1988","unstructured":"Bearman SI, Appelbaum FR, Buckner CD, Petersen FB, Fisher LD, Clift RA, Thomas ED (1988) Regimen-related toxicity in patients undergoing bone marrow transplantation. J Clin Oncol 6:1562\u20131568","journal-title":"J Clin Oncol"},{"key":"721_CR11","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1681\/ASN.V94710","volume":"9","author":"CR Nolan","year":"1998","unstructured":"Nolan CR, Anderson RJ (1998) Hospital-acquired acute renal failure. J Am Soc Nephrol 9:710\u2013718","journal-title":"J Am Soc Nephrol"},{"key":"721_CR12","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/ki.1996.380","volume":"50","author":"F Liano","year":"1996","unstructured":"Liano F, Pascual J (1996) Epidemiology of acute renal failure: a prospective, multicenter, community-based study. Madrid Acute Renal Failure Study Group. Kidney Int 50:811\u2013818","journal-title":"Kidney Int"},{"key":"721_CR13","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1159\/000186651","volume":"59","author":"AB Groeneveld","year":"1991","unstructured":"Groeneveld AB, Tran DD, van der MJ, Nauta JJ, Thijs LG (1991) Acute renal failure in the medical intensive care unit: predisposing, complicating factors and outcome. Nephron 59:602\u2013610","journal-title":"Nephron"},{"key":"721_CR14","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s001340051281","volume":"26","author":"A de Mendonca","year":"2000","unstructured":"de Mendonca A, Vincent JL, Suter PM, Moreno R, Dearden NM, Antonelli M, Takala J, Sprung C, Cantraine F (2000) Acute renal failure in the ICU: risk factors and outcome evaluated by the SOFA score. Intensive Care Med 26:915\u2013921","journal-title":"Intensive Care Med"},{"key":"721_CR15","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/00003246-199602000-00003","volume":"24","author":"FG Brivet","year":"1996","unstructured":"Brivet FG, Kleinknecht DJ, Loirat P, Landais PJ (1996) Acute renal failure in intensive care units\u2013causes, outcome, and prognostic factors of hospital mortality; a prospective, multicenter study. French Study Group on Acute Renal Failure. Crit Care Med 24:192\u2013198","journal-title":"Crit Care Med"},{"key":"721_CR16","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1365-2044.1983.tb12153.x","volume":"38","author":"RG Wilkins","year":"1983","unstructured":"Wilkins RG, Faragher EB (1983) Acute renal failure in an intensive care unit: incidence, prediction and outcome. Anaesthesia 38:628\u2013634","journal-title":"Anaesthesia"},{"key":"721_CR17","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/qjmed\/90.12.781","volume":"90","author":"IH Khan","year":"1997","unstructured":"Khan IH, Catto GR, Edward N, Macleod AM (1997) Acute renal failure: factors influencing nephrology referral and outcome. QJM 90:781\u2013785","journal-title":"QJM"},{"key":"721_CR18","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/bmj.306.6876.481","volume":"306","author":"TG Feest","year":"1993","unstructured":"Feest TG, Round A, Hamad S (1993) Incidence of severe acute renal failure in adults: results of a community based study. BMJ 306:481\u2013483","journal-title":"BMJ"},{"key":"721_CR19","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0002-9343(82)90181-4","volume":"73","author":"HH Rasmussen","year":"1982","unstructured":"Rasmussen HH, Ibels LS (1982) Acute renal failure. Multivariate analysis of causes and risk factors. Am J Med 73:211\u2013218","journal-title":"Am J Med"},{"key":"721_CR20","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0002-9343(83)90618-6","volume":"74","author":"SH Hou","year":"1983","unstructured":"Hou SH, Bushinsky DA, Wish JB, Cohen JJ, Harrington JT (1983) Hospital-acquired renal insufficiency: a prospective study. Am J Med 74:243\u2013248","journal-title":"Am J Med"},{"key":"721_CR21","first-page":"49","volume":"19","author":"D Kleinknecht","year":"1998","unstructured":"Kleinknecht D, Pallot JL (1998) Epidemiology and prognosis of acute renal insufficiency in 1997. Recent data. Nephrologie 19:49\u201355","journal-title":"Nephrologie"},{"key":"721_CR22","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0272-6386(12)81128-0","volume":"17","author":"J Kaufman","year":"1991","unstructured":"Kaufman J, Dhakal M, Patel B, Hamburger R (1991) Community-acquired acute renal failure. Am J Kidney Dis 17:191\u2013198","journal-title":"Am J Kidney Dis"},{"issue":"Suppl 7","key":"721_CR23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/ndt\/13.suppl_7.25","volume":"13","author":"A Baraldi","year":"1998","unstructured":"Baraldi A, Ballestri M, Rapana R, Lucchi L, Borella P, Leonelli M, Furci L, Lusvarghi E (1998) Acute renal failure of medical type in an elderly population. Nephrol Dial Transplant 13(Suppl 7):25\u201329","journal-title":"Nephrol Dial Transplant"},{"key":"721_CR24","doi-asserted-by":"crossref","DOI":"10.1007\/1-4020-2586-6","volume-title":"Clinical nephrotoxins: renal injury from drugs and chemicals","author":"ME deBroe","year":"2003","unstructured":"deBroe ME, Porter GA, Bennett WM, Verpooten GA (2003) Clinical nephrotoxins: Renal injury from drugs and chemicals, 2 edn. Kluwer Academic, Dordrecht","edition":"2"},{"key":"721_CR25","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1093\/ndt\/16.2.230","volume":"16","author":"C Ronco","year":"2001","unstructured":"Ronco C, Zanella M, Brendolan A, Milan M, Canato G, Zamperetti N, Bellomo R (2001) Management of severe acute renal failure in critically ill patients: an international survey in 345 centres. Nephrol Dial Transplant 16:230\u2013237","journal-title":"Nephrol Dial Transplant"},{"key":"721_CR26","first-page":"523","volume":"18","author":"A Vijayan","year":"1998","unstructured":"Vijayan A, Miller SB (1998) Acute renal failure: prevention and nondialytic therapy. Semin Nephrol 18:523\u2013532","journal-title":"Semin Nephrol"},{"key":"721_CR27","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1038\/ki.1994.417","volume":"46","author":"RA Zager","year":"1994","unstructured":"Zager RA (1994) Acute renal failure in the setting of bone marrow transplantation. Kidney Int 46:1443\u20131458","journal-title":"Kidney Int"},{"key":"721_CR28","first-page":"761","volume":"18","author":"E Gruss","year":"1996","unstructured":"Gruss E, Tomas JF, Bernis C, Rodriguez F, Traver JA, Fernandez RJ (1996) Nephroprotective effect of cilastatin in allogeneic bone marrow transplantation. Results from a retrospective analysis. Bone Marrow Transplant 18:761\u2013765","journal-title":"Bone Marrow Transplant"},{"key":"721_CR29","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1159\/000168889","volume":"15","author":"E Gruss","year":"1995","unstructured":"Gruss E, Bernis C, Tomas JF, Garcia-Canton C, Figuera A, Mottellon JL, Paraiso V, Traver JA, Fernandez-Ranada JM (1995) Acute renal failure in patients following bone marrow transplantation: prevalence, risk factors and outcome. Am J Nephrol 15:473\u2013479","journal-title":"Am J Nephrol"},{"key":"721_CR30","first-page":"1477","volume":"44","author":"E Gruss","year":"1993","unstructured":"Gruss E, Garciacanton C, Tomas JF, Bernis C, Figuera A, Berberana M, Paraiso V, Hernandezjaraz J, Fdzranada JM, Traver JA (1993) Risk factors for the development of acute renal failure during bone marrow transplantation. Kidney Int 44:1477","journal-title":"Kidney Int"},{"key":"721_CR31","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1046\/j.1523-1755.2002.00455.x","volume":"62","author":"CR Parikh","year":"2002","unstructured":"Parikh CR, McSweeney PA, Korular D, Ecder T, Merouani A, Taylor J, Slat-Vasquez V, Shpall EJ, Jones RB, Bearman SI, Schrier RW (2002) Renal dysfunction in allogeneic hematopoietic cell transplantation. Kidney Int 62:566\u2013573","journal-title":"Kidney Int"},{"key":"721_CR32","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000045561","volume":"84","author":"S Herget-Rosenthal","year":"2000","unstructured":"Herget-Rosenthal S, Uppenkamp M, Beelen D, Kohl D, Kribben A (2000) Renal complications of high-dose chemotherapy and peripheral blood stem cell transplantation. Nephron 84:136\u2013141","journal-title":"Nephron"},{"key":"721_CR33","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1200\/JCO.1991.9.7.1224","volume":"9","author":"TJ Nevill","year":"1991","unstructured":"Nevill TJ, Barnett MJ, Klingemann HG, Reece DE, Shepherd JD, Phillips GL (1991) Regimen-related toxicity of a busulfan-cyclophosphamide conditioning regimen in 70 patients undergoing allogeneic bone marrow transplantation. J Clin Oncol 9:1224\u20131232","journal-title":"J Clin Oncol"},{"key":"721_CR34","first-page":"515","volume":"10","author":"D Cowen","year":"1992","unstructured":"Cowen D, Richaud P, Marit G, Cony-Makhoul P, Trouette R, Faberes C, Reiffers J (1992) Regimen-related toxicity in patients undergoing BMT with total body irradiation using a sweeping beam technique. Bone Marrow Transplant 10:515\u2013519","journal-title":"Bone Marrow Transplant"},{"key":"721_CR35","first-page":"449","volume":"14","author":"D Przepiorka","year":"1994","unstructured":"Przepiorka D, Ippoliti C, Giralt S, van Beisen K, Mehra R, Deisseroth AB, Andersson B, Luna M, Cork A, Lee M (1994) A phase I-II study of high-dose thiotepa, busulfan and cyclophosphamide as a preparative regimen for allogeneic marrow transplantation. Bone Marrow Transplant 14:449\u2013453","journal-title":"Bone Marrow Transplant"},{"key":"721_CR36","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1542\/pir.23-2-47","volume":"23","author":"JC Chan","year":"2002","unstructured":"Chan JC, Williams DM, Roth KS (2002) Kidney failure in infants and children. Pediatr Rev 23:47\u201360","journal-title":"Pediatr Rev"},{"key":"721_CR37","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00008480-200204000-00007","volume":"14","author":"SP Andreoli","year":"2002","unstructured":"Andreoli SP (2002) Acute renal failure. Curr Opin Pediatr 14:183\u2013188","journal-title":"Curr Opin Pediatr"},{"key":"721_CR38","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1053\/j.ajkd.2004.09.028","volume":"45","author":"S Hui-Stickle","year":"2005","unstructured":"Hui-Stickle S, Brewer ED, Goldstein SL (2005) Pediatric ARF epidemiology at a tertiary care center from 1999 to 2001. Am J Kidney Dis 45:96\u2013101","journal-title":"Am J Kidney Dis"},{"key":"721_CR39","first-page":"91","volume":"49","author":"NE Moghal","year":"1998","unstructured":"Moghal NE, Brocklebank JT, Meadow SR (1998) A review of acute renal failure in children: incidence, etiology and outcome. Clin Nephrol 49:91\u201395","journal-title":"Clin Nephrol"},{"key":"721_CR40","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1001\/archpedi.156.9.893","volume":"156","author":"DM Williams","year":"2002","unstructured":"Williams DM, Sreedhar SS, Mickell JJ, Chan JC (2002) Acute kidney failure: a pediatric experience over 20\u00a0years. Arch Pediatr Adolesc Med 156:893\u2013900","journal-title":"Arch Pediatr Adolesc Med"},{"key":"721_CR41","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/BF00849230","volume":"1","author":"FB Stapleton","year":"1987","unstructured":"Stapleton FB, Jones DP, Green RS (1987) Acute renal failure in neonates: incidence, etiology and outcome. Pediatr Nephrol 1:314\u2013320","journal-title":"Pediatr Nephrol"},{"key":"721_CR42","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s004670050068","volume":"14","author":"JB Gouyon","year":"2000","unstructured":"Gouyon JB, Guignard JP (2000) Management of acute renal failure in newborns. Pediatr Nephrol 14:1037\u20131044","journal-title":"Pediatr Nephrol"},{"key":"721_CR43","first-page":"7","volume":"28","author":"KP Mehta","year":"1991","unstructured":"Mehta KP (1991) Neonatal renal failure. Indian Pediatr 28:7\u20139","journal-title":"Indian Pediatr"},{"key":"721_CR44","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s004670050048","volume":"14","author":"P Toth-Heyn","year":"2000","unstructured":"Toth-Heyn P, Drukker A, Guignard JP (2000) The stressed neonatal kidney: from pathophysiology to clinical management of neonatal vasomotor nephropathy. Pediatr Nephrol 14:227\u2013239","journal-title":"Pediatr Nephrol"},{"key":"721_CR45","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/01.pcc.0000256612.40265.67","volume":"8","author":"D Bailey","year":"2007","unstructured":"Bailey D, Phan V, Litalien C, Ducruet T, Merouani A, Lacroix J, Gauvin F (2007) Risk factors of acute renal failure in critically ill children: A prospective descriptive epidemiological study. Pediatr Crit Care Med 8:29\u201335","journal-title":"Pediatr Crit Care Med"},{"key":"721_CR46","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S1695-4033(04)78437-4","volume":"61","author":"VA Medina","year":"2004","unstructured":"Medina VA, Lopez-Herce CJ, Lopez FY, Anton GM, Concha TA, Rey GC, Santos RF (2004) Acute renal failure in critically-ill children. A preliminary study. An Pediatr (Barc) 61:509\u2013514","journal-title":"An Pediatr (Barc)"},{"key":"721_CR47","volume-title":"Akute Niereninsuffizienz innerhalb der ersten 30 Tage nach Knochenmarktransplantation bei Kindern","author":"K Kentouche","year":"1999","unstructured":"Kentouche K (1999) Akute Niereninsuffizienz innerhalb der ersten 30 Tage nach Knochenmarktransplantation bei Kindern. Friedrich-Schiller-University, Jena"},{"key":"721_CR48","first-page":"383","volume":"7","author":"SK Van Why","year":"1991","unstructured":"Van Why SK, Friedman AL, Wei LJ, Hong R (1991) Renal insufficiency after bone marrow transplantation in children. Bone Marrow Transplant 7:383\u2013388","journal-title":"Bone Marrow Transplant"},{"key":"721_CR49","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/sj.bmt.1701388","volume":"22","author":"JE Kist-van Holthe","year":"1998","unstructured":"Kist-van Holthe JE, van Zwet JM, Brand R, van Weel MH, Vossen JM, van der Heijden AJ (1998) Bone marrow transplantation in children: consequences for renal function shortly after and 1\u00a0year post-BMT. Bone Marrow Transplant 22:559\u2013564","journal-title":"Bone Marrow Transplant"},{"key":"721_CR50","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/sj.bmt.1703337","volume":"29","author":"A Balduzzi","year":"2002","unstructured":"Balduzzi A, Valsecchi MG, Silvestri D, Locatelli F, Manfredini L, Busca A, Iori AP, Messina C, Prete A, Andolina M, Porta F, Favre C, Ceppi S, Giorgiani G, Lanino E, Rovelli A, Fagioli F, De Fusco C, Rondelli R, Uderzo C (2002) Transplant-related toxicity and mortality: an AIEOP prospective study in 636 pediatric patients transplanted for acute leukemia. Bone Marrow Transplant 29:93\u2013100","journal-title":"Bone Marrow Transplant"},{"key":"721_CR51","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2165\/00128072-200103110-00004","volume":"3","author":"C Litalien","year":"2001","unstructured":"Litalien C, Jacqz-Aigrain E (2001) Risks and benefits of nonsteroidal anti-inflammatory drugs in children: a comparison with paracetamol. Paediatr Drugs 3:817\u2013858","journal-title":"Paediatr Drugs"},{"key":"721_CR52","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1136\/adc.2006.103564","volume":"92","author":"CM John","year":"2007","unstructured":"John CM, Shukla R, Jones CA (2007) Using NSAID in volume depleted children can precipitate acute renal failure. Arch Dis Child 92:524\u2013526","journal-title":"Arch Dis Child"},{"key":"721_CR53","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1136\/adc.2002.024141","volume":"89","author":"NE Moghal","year":"2004","unstructured":"Moghal NE, Hegde S, Eastham KM (2004) Ibuprofen and acute renal failure in a toddler. Arch Dis Child 89:276\u2013277","journal-title":"Arch Dis Child"},{"key":"721_CR54","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s00431-003-1392-7","volume":"163","author":"T Ulinski","year":"2004","unstructured":"Ulinski T, Guigonis V, Dunan O, Bensman A (2004) Acute renal failure after treatment with non-steroidal anti-inflammatory drugs. Eur J Pediatr 163:148\u2013150","journal-title":"Eur J Pediatr"},{"key":"721_CR55","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s00467-005-1966-x","volume":"20","author":"I Krause","year":"2005","unstructured":"Krause I, Cleper R, Eisenstein B, Davidovits M (2005) Acute renal failure, associated with non-steroidal anti-inflammatory drugs in healthy children. Pediatr Nephrol 20:1295\u20131298","journal-title":"Pediatr Nephrol"},{"key":"721_CR56","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1177\/0009922806292813","volume":"45","author":"C Kallanagowdar","year":"2006","unstructured":"Kallanagowdar C, LeBreton A, Aviles DH (2006) Acute renal failure. Clin Pediatr 45:771\u2013773","journal-title":"Clin Pediatr"},{"key":"721_CR57","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1007\/s00467-006-0252-x","volume":"21","author":"JT Fletcher","year":"2006","unstructured":"Fletcher JT, Graf N, Scarman A, Saleh H, Alexander SI (2006) Nephrotoxicity with cyclooxygenase 2 inhibitor use in children. Pediatr Nephrol 21:1893\u20131897","journal-title":"Pediatr Nephrol"},{"key":"721_CR58","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1056\/NEJMoa021907","volume":"347","author":"FK Chan","year":"2002","unstructured":"Chan FK, Hung LC, Suen BY, Wu JC, Lee KC, Leung VK, Hui AJ, To KF, Leung WK, Wong VW, Chung SC, Sung JJ (2002) Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis. N Engl J Med 347:2104\u20132110","journal-title":"N Engl J Med"},{"key":"721_CR59","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.2174\/1381612053764922","volume":"11","author":"HF Cheng","year":"2005","unstructured":"Cheng HF, Harris RC (2005) Renal effects of non-steroidal anti-inflammatory drugs and selective cyclooxygenase-2 inhibitors. Curr Pharm Des 11:1795\u20131804","journal-title":"Curr Pharm Des"},{"key":"721_CR60","unstructured":"Shah SS, Ohlsson A (2006) Ibuprofen for the prevention of patent ductus arteriosus in preterm and\/or low birth weight infants. Cochrane Database Syst Rev CD004213"},{"key":"721_CR61","doi-asserted-by":"crossref","unstructured":"Ohlsson A, Walia R, Shah S (2005) Ibuprofen for the treatment of patent ductus arteriosus in preterm and\/or low birth weight infants. Cochrane Database Syst Rev CD003481","DOI":"10.1002\/14651858.CD003481.pub2"},{"key":"721_CR62","doi-asserted-by":"crossref","unstructured":"Herrera C, Holberton J, Davis P (2007) Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev CD003480","DOI":"10.1002\/14651858.CD003480.pub3"},{"key":"721_CR63","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2165\/00002018-200124010-00002","volume":"24","author":"L Cuzzolin","year":"2001","unstructured":"Cuzzolin L, Dal Cere M, Fanos V (2001) NSAID-induced nephrotoxicity from the fetus to the child. Drug Saf 24:9\u201318","journal-title":"Drug Saf"},{"key":"721_CR64","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s00467-003-1338-3","volume":"19","author":"D Benini","year":"2004","unstructured":"Benini D, Fanos V, Cuzzolin L, Tato L (2004) In utero exposure to nonsteroidal anti-inflammatory drugs: neonatal renal failure. Pediatr Nephrol 19:232\u2013234","journal-title":"Pediatr Nephrol"},{"key":"721_CR65","first-page":"321","volume":"69","author":"S Van Biervliet","year":"2006","unstructured":"Van Biervliet S, Raes A, Vande WJ, Van Winckel M, Robberecht E, Praet M (2006) Mesalazine interstitial nephritis presenting as colitis ulcerosa exacerbation. Acta Gastroenterol Belg 69:321\u2013322","journal-title":"Acta Gastroenterol Belg"},{"key":"721_CR66","first-page":"349","volume-title":"Acute renal failure: a companion to Brenner and Rector\u2019s the kidney","author":"JJ Dillon","year":"2001","unstructured":"Dillon JJ (2001) Nephrotoxicity from antibacterial, antifungal, and antiviral drugs. In: Molitoris BA, Finn WF (eds) Acute renal failure: a companion to Brenner and Rector\u2019s the kidney. WB Saunders, Philadelphia, pp 349\u2013364"},{"key":"721_CR67","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.taap.2007.05.004","volume":"223","author":"C Martinez-Salgado","year":"2007","unstructured":"Martinez-Salgado C, Lopez-Hernandez FJ, Lopez-Novoa JM (2007) Glomerular nephrotoxicity of aminoglycosides. Toxicol Appl Pharmacol 223:86\u201398","journal-title":"Toxicol Appl Pharmacol"},{"key":"721_CR68","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1056\/NEJM197702172960701","volume":"296","author":"CR Smith","year":"1977","unstructured":"Smith CR, Baughman KL, Edwards CQ, Rogers JF, Lietman PS (1977) Controlled comparison of amikacin and gentamicin. N Engl J Med 296:349\u2013353","journal-title":"N Engl J Med"},{"key":"721_CR69","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1046\/j.1525-1497.1998.00224.x","volume":"13","author":"DL Paterson","year":"1998","unstructured":"Paterson DL, Robson JM, Wagener MM (1998) Risk factors for toxicity in elderly patients given aminoglycosides once daily. J Gen Intern Med 13:735\u2013739","journal-title":"J Gen Intern Med"},{"key":"721_CR70","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0272-6386(86)80103-2","volume":"8","author":"CR Smith","year":"1986","unstructured":"Smith CR, Moore RD, Lietman PS (1986) Studies of risk factors for aminoglycoside nephrotoxicity. Am J Kidney Dis 8:308\u2013313","journal-title":"Am J Kidney Dis"},{"key":"721_CR71","doi-asserted-by":"crossref","first-page":"352","DOI":"10.7326\/0003-4819-100-3-352","volume":"100","author":"RD Moore","year":"1984","unstructured":"Moore RD, Smith CR, Lipsky JJ, Mellits ED, Lietman PS (1984) Risk factors for nephrotoxicity in patients treated with aminoglycosides. Ann Intern Med 100:352\u2013357","journal-title":"Ann Intern Med"},{"key":"721_CR72","first-page":"987","volume-title":"Pediatric nephrology","author":"RW Chesney","year":"2004","unstructured":"Chesney RW, Jones DP (2004) Nephrotoxins. In: Avner ED, Harmon WE, Niaudet P (eds) Pediatric nephrology, 5th edn. Lippincott Williams and Wilkins, Philadelphia, pp 987\u20131004","edition":"5"},{"key":"721_CR73","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/00007691-200110000-00002","volume":"23","author":"EV Uijtendaal","year":"2001","unstructured":"Uijtendaal EV, Rademaker CM, Schobben AF, Fleer A, Kramer WL, van Vught AJ, Kimpen JL, van Dijk A (2001) Once-daily versus multiple-daily gentamicin in infants and children. Ther Drug Monit 23:506\u2013513","journal-title":"Ther Drug Monit"},{"key":"721_CR74","first-page":"CD002009","volume":"3","author":"AR Smyth","year":"2006","unstructured":"Smyth AR, Tan KH (2006) Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis. Cochrane Database Syst Rev 3:CD002009","journal-title":"Cochrane Database Syst Rev"},{"key":"721_CR75","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/1-4020-2586-6_8","volume-title":"Clinical nephrotoxins","author":"GA Verpooten","year":"2003","unstructured":"Verpooten GA, Tulkens PM, Molitoris BA (2003) Aminoglycosides and vancomycin. In: deBroe ME, Porter GA, Bennett WM, Verpooten GA (eds) Clinical nephrotoxins, 2nd edn. Kluwer Academic, Dordrecht, pp 151\u2013170","edition":"2"},{"key":"721_CR76","doi-asserted-by":"crossref","unstructured":"Rao SC, Ahmed M, Hagan R (2006) One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or proven sepsis in neonates. Cochrane Database Syst Rev CD005091","DOI":"10.1002\/14651858.CD005091.pub2"},{"key":"721_CR77","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/s004670050386","volume":"11","author":"BM Tune","year":"1997","unstructured":"Tune BM (1997) Nephrotoxicity of beta-lactam antibiotics: mechanisms and strategies for prevention. Pediatr Nephrol 11:768\u2013772","journal-title":"Pediatr Nephrol"},{"key":"721_CR78","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2165\/00002018-199920030-00005","volume":"20","author":"V Fanos","year":"1999","unstructured":"Fanos V, Cataldi L (1999) Antibacterial-induced nephrotoxicity in the newborn. Drug Saf 20:245\u2013267","journal-title":"Drug Saf"},{"key":"721_CR79","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s00467-006-0318-9","volume":"22","author":"JE Tong","year":"2007","unstructured":"Tong JE, Howell DN, Foreman JW (2007) Drug-induced granulomatous interstitial nephritis in a pediatric patient. Pediatr Nephrol 22:306\u2013309","journal-title":"Pediatr Nephrol"},{"key":"721_CR80","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1007\/s00467-006-0401-2","volume":"22","author":"M Mohkam","year":"2007","unstructured":"Mohkam M, Karimi A, Gharib A, Daneshmand H, Khatami A, Ghojevand N, Sharifian M (2007) Ceftriaxone associated nephrolithiasis: a prospective study in 284 children. Pediatr Nephrol 22:690\u2013694","journal-title":"Pediatr Nephrol"},{"key":"721_CR81","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1136\/adc.2003.044156","volume":"89","author":"Z Avci","year":"2004","unstructured":"Avci Z, Koktener A, Uras N, Catal F, Karadag A, Tekin O, Degirmencioglu H, Baskin E (2004) Nephrolithiasis associated with ceftriaxone therapy: a prospective study in 51 children. Arch Dis Child 89:1069\u20131072","journal-title":"Arch Dis Child"},{"key":"721_CR82","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/pbc.20839","volume":"50","author":"G Kapur","year":"2008","unstructured":"Kapur G, Valentini RP, Mattoo TK, Warrier I, Imam AA (2008) Ceftriaxone induced hemolysis complicated by acute renal failure. Pediatr Blood Cancer 50:139\u2013142","journal-title":"Pediatr Blood Cancer"},{"key":"721_CR83","doi-asserted-by":"crossref","first-page":"F514","DOI":"10.1136\/adc.2004.060434","volume":"90","author":"L Cataldi","year":"2005","unstructured":"Cataldi L, Leone R, Moretti U, De Mitri B, Fanos V, Ruggeri L, Sabatino G, Torcasio F, Zanardo V, Attardo G, Riccobene F, Martano C, Benini D, Cuzzolin L (2005) Potential risk factors for the development of acute renal failure in preterm newborn infants: a case-control study. Arch Dis Child Fetal Neonatal Ed 90:F514\u2013F519","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"721_CR84","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s004670050181","volume":"10","author":"V Fanos","year":"1996","unstructured":"Fanos V, Mussap M, Verlato G, Plebani M, Padovani EM (1996) Evaluation of antibiotic-induced nephrotoxicity in preterm neonates by determining urinary alpha 1-microglobulin. Pediatr Nephrol 10:645\u2013647","journal-title":"Pediatr Nephrol"},{"key":"721_CR85","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/1-4020-2586-6_9","volume-title":"Clinical nephrotoxins","author":"C Cojocel","year":"2003","unstructured":"Cojocel C (2003) Beta-lactam antibiotics. In: deBroe ME, Porter GA, Bennett WM, Verpooten GA (eds) Clinical nephrotoxins, 2nd edn. Kluwer Academic, Dordrecht, pp 171\u2013198","edition":"2"},{"key":"721_CR86","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1177\/106002809703100314","volume":"31","author":"VS Watkins","year":"1997","unstructured":"Watkins VS, Polk RE, Stotka JL (1997) Drug interactions of macrolides: emphasis on dirithromycin. Ann Pharmacother 31:349\u2013356","journal-title":"Ann Pharmacother"},{"key":"721_CR87","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/1-4020-2586-6_11","volume-title":"Clinical nephrotoxins","author":"CA Vaamonde","year":"2003","unstructured":"Vaamonde CA, Contreras GN, Diego JM (2003) Sulfonamides, sulfadiazine, trimethoprim-sulfamethoxazole, pentamidine, pyrimethamine, dapsone, quinolones. In: deBroe ME, Porter GA, Bennett WM, Verpooten GA (eds) Clinical nephrotoxins, 2nd edn. Kluwer Academic, Dordrecht, pp 223\u2013247","edition":"2"},{"key":"721_CR88","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/00043426-200407000-00004","volume":"26","author":"RD Goldman","year":"2004","unstructured":"Goldman RD, Koren G (2004) Amphotericin B nephrotoxicity in children. J Pediatr Hematol Oncol 26:421\u2013426","journal-title":"J Pediatr Hematol Oncol"},{"key":"721_CR89","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2165\/00148581-200709030-00001","volume":"9","author":"G Koren","year":"2007","unstructured":"Koren G, Chen N, Aleksa K (2007) Drug-induced nephrotoxicity in children: pharmacologically based prevention of long-term impairment. Paediatr Drugs 9:139\u2013142","journal-title":"Paediatr Drugs"},{"key":"721_CR90","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1179\/joc.2000.12.6.463","volume":"12","author":"V Fanos","year":"2000","unstructured":"Fanos V, Cataldi L (2000) Amphotericin B-induced nephrotoxicity: a review. J Chemother 12:463\u2013470","journal-title":"J Chemother"},{"key":"721_CR91","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1086\/516321","volume":"26","author":"A Pathak","year":"1998","unstructured":"Pathak A, Pien FD, Carvalho L (1998) Amphotericin B use in a community hospital, with special emphasis on side effects. Clin Infect Dis 26:334\u2013338","journal-title":"Clin Infect Dis"},{"key":"721_CR92","first-page":"22N","volume":"88","author":"JS Clements Jr","year":"1990","unstructured":"Clements JS Jr, Peacock JE Jr (1990) Amphotericin B revisited: reassessment of toxicity. Am J Med 88:22N\u201327N","journal-title":"Am J Med"},{"key":"721_CR93","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/jac\/43.2.267","volume":"43","author":"AD Luber","year":"1999","unstructured":"Luber AD, Maa L, Lam M, Guglielmo BJ (1999) Risk factors for amphotericin B-induced nephrotoxicity. J Antimicrob Chemother 43:267\u2013271","journal-title":"J Antimicrob Chemother"},{"key":"721_CR94","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/00007611-198809000-00007","volume":"81","author":"RS Stein","year":"1988","unstructured":"Stein RS, Albridge K, Lenox RK, Ray W, Flexner JM (1988) Nephrotoxicity in leukemic patients receiving empirical amphotericin B and aminoglycosides. South Med J 81:1095\u20131099","journal-title":"South Med J"},{"key":"721_CR95","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0002-9343(01)00928-7","volume":"111","author":"S Harbarth","year":"2001","unstructured":"Harbarth S, Pestotnik SL, Lloyd JF, Burke JP, Samore MH (2001) The epidemiology of nephrotoxicity associated with conventional amphotericin B therapy. Am J Med 111:528\u2013534","journal-title":"Am J Med"},{"key":"721_CR96","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1046\/j.1523-1755.2001.00948.x","volume":"60","author":"DW Bates","year":"2001","unstructured":"Bates DW, Su L, Yu DT, Chertow GM, Seger DL, Gomes DR, Platt R (2001) Correlates of acute renal failure in patients receiving parenteral amphotericin B. Kidney Int 60:1452\u20131459","journal-title":"Kidney Int"},{"key":"721_CR97","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00075198-200112000-00002","volume":"7","author":"S Costa","year":"2001","unstructured":"Costa S, Nucci M (2001) Can we decrease amphotericin nephrotoxicity? Curr Opin Crit Care 7:379\u2013383","journal-title":"Curr Opin Crit Care"},{"key":"721_CR98","doi-asserted-by":"crossref","first-page":"257","DOI":"10.7326\/0003-4819-126-4-199702150-00001","volume":"126","author":"JP Lalezari","year":"1997","unstructured":"Lalezari JP, Stagg RJ, Kuppermann BD, Holland GN, Kramer F, Ives DV, Youle M, Robinson MR, Drew WL, Jaffe HS (1997) Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial. Ann Intern Med 126:257\u2013263","journal-title":"Ann Intern Med"},{"key":"721_CR99","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1053\/j.ajkd.2005.02.010","volume":"45","author":"H Izzedine","year":"2005","unstructured":"Izzedine H, Launay-Vacher V, Deray G (2005) Antiviral drug-induced nephrotoxicity. Am J Kidney Dis 45:804\u2013817","journal-title":"Am J Kidney Dis"},{"key":"721_CR100","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/1-4020-2586-6_12","volume-title":"Clinical nephrotoxins","author":"JS Berns","year":"2003","unstructured":"Berns JS, Cohen RM, Rudnick MR (2003) Antiviral agents. In: deBroe ME, Porter GA, Bennett WM, Verpooten GA (eds) Clinical nephrotoxins, 2nd edn. Kluwer Academic, Dordrecht, pp 249\u2013262","edition":"2"},{"key":"721_CR101","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1590\/S0104-42302005000500019","volume":"51","author":"LR Pacheco","year":"2005","unstructured":"Pacheco LR, Tavares HM, Moyses NM, Dantas M, Rocha LS, Ribeiro KM, Figueiredo JF (2005) Acute renal failure related to intravenous acyclovir. Rev Assoc Med Bras 51:275\u2013278","journal-title":"Rev Assoc Med Bras"},{"key":"721_CR102","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s00467-002-0867-5","volume":"17","author":"G Vomiero","year":"2002","unstructured":"Vomiero G, Carpenter B, Robb I, Filler G (2002) Combination of ceftriaxone and acyclovir - an underestimated nephrotoxic potential? Pediatr Nephrol 17:633\u2013637","journal-title":"Pediatr Nephrol"},{"key":"721_CR103","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000167987","volume":"9","author":"G Deray","year":"1989","unstructured":"Deray G, Martinez F, Katlama C, Levaltier B, Beaufils H, Danis M, Rozenheim M, Baumelou A, Dohin E, Gentilini M (1989) Foscarnet nephrotoxicity: mechanism, incidence and prevention. Am J Nephrol 9:316\u2013321","journal-title":"Am J Nephrol"},{"key":"721_CR104","first-page":"315","volume":"29","author":"P Cacoub","year":"1988","unstructured":"Cacoub P, Deray G, Baumelou A, Le Hoang P, Rozenbaum W, Gentilini M, Soubrie C, Rousselie R, Jacobs C (1988) Acute renal failure induced by foscarnet: 4 cases. Clin Nephrol 29:315\u2013318","journal-title":"Clin Nephrol"},{"issue":"Suppl 1","key":"721_CR105","first-page":"S11","volume":"5","author":"MA Jacobson","year":"1992","unstructured":"Jacobson MA (1992) Review of the toxicities of foscarnet. J Acquir Immune Defic Syndr 5(Suppl 1):S11\u2013S17","journal-title":"J Acquir Immune Defic Syndr"},{"key":"721_CR106","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1093\/ndt\/13.9.2368","volume":"13","author":"E Chatelain","year":"1998","unstructured":"Chatelain E, Deminiere C, Lacut JY, Potaux L (1998) Severe renal failure and polyneuritis induced by foscarnet. Nephrol Dial Transplant 13:2368\u20132369","journal-title":"Nephrol Dial Transplant"},{"key":"721_CR107","doi-asserted-by":"crossref","first-page":"332","DOI":"10.7326\/0003-4819-113-4-332_1","volume":"113","author":"G Deray","year":"1990","unstructured":"Deray G, Katlama C, Dohin E (1990) Prevention of foscarnet nephrotoxicity. Ann Intern Med 113:332","journal-title":"Ann Intern Med"},{"key":"721_CR108","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1182\/blood.V99.4.1159","volume":"99","author":"P Reusser","year":"2002","unstructured":"Reusser P, Einsele H, Lee J, Volin L, Rovira M, Engelhard D, Finke J, Cordonnier C, Link H, Ljungman P (2002) Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation. Blood 99:1159\u20131164","journal-title":"Blood"},{"key":"721_CR109","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1681\/ASN.2006040347","volume":"18","author":"R Coppo","year":"2007","unstructured":"Coppo R, Peruzzi L, Amore A, Piccoli A, Cochat P, Stone R, Kirschstein M, Linne T (2007) IgACE: A placebo-controlled, randomized trial of angiotensin-converting enzyme inhibitors in children and young people with IgA nephropathy and moderate proteinuria. J Am Soc Nephrol 18:1880\u20131888","journal-title":"J Am Soc Nephrol"},{"key":"721_CR110","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/s00467-007-0485-3","volume":"22","author":"TK Mattoo","year":"2007","unstructured":"Mattoo TK (2007) Medical management of vesicoureteral reflux. Pediatr Nephrol 22:1113\u20131120","journal-title":"Pediatr Nephrol"},{"key":"721_CR111","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00467-006-0399-5","volume":"22","author":"RJ Hogg","year":"2007","unstructured":"Hogg RJ, Delucchi A, Sakihara G, Wells TG, Tenney F, Batisky DL, Blumer JL, Vogt BA, Lo MW, Hand E, Panebianco D, Rippley R, Shaw W, Shahinfar S (2007) A multicenter study of the pharmacokinetics of lisinopril in pediatric patients with hypertension. Pediatr Nephrol 22:695\u2013701","journal-title":"Pediatr Nephrol"},{"key":"721_CR112","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2165\/00148581-200608010-00005","volume":"8","author":"K Momma","year":"2006","unstructured":"Momma K (2006) ACE inhibitors in pediatric patients with heart failure. Paediatr Drugs 8:55\u201369","journal-title":"Paediatr Drugs"},{"key":"721_CR113","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2165\/00148581-200507010-00003","volume":"7","author":"RF Robinson","year":"2005","unstructured":"Robinson RF, Nahata MC, Batisky DL, Mahan JD (2005) Pharmacologic treatment of chronic pediatric hypertension. Paediatr Drugs 7:27\u201340","journal-title":"Paediatr Drugs"},{"key":"721_CR114","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1007\/s00467-004-1554-5","volume":"19","author":"KF Hilgers","year":"2004","unstructured":"Hilgers KF, Dotsch J, Rascher W, Mann JF (2004) Treatment strategies in patients with chronic renal disease: ACE inhibitors, angiotensin receptor antagonists, or both? Pediatr Nephrol 19:956\u2013961","journal-title":"Pediatr Nephrol"},{"key":"721_CR115","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1523-1755.2004.00802.x","volume":"66","author":"E Wuhl","year":"2004","unstructured":"Wuhl E, Mehls O, Schaefer F (2004) Antihypertensive and antiproteinuric efficacy of ramipril in children with chronic renal failure. Kidney Int 66:768\u2013776","journal-title":"Kidney Int"},{"key":"721_CR116","first-page":"216","volume":"17","author":"WA Olowu","year":"2006","unstructured":"Olowu WA, Adenowo OA, Elusiyan JB (2006) Reversible renal failure in hypertensive idiopathic nephrotics treated with captopril. Saudi J Kidney Dis Transplant 17:216\u2013221","journal-title":"Saudi J Kidney Dis Transplant"},{"key":"721_CR117","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1592\/phco.26.9.1348","volume":"26","author":"CD Hanevold","year":"2006","unstructured":"Hanevold CD (2006) Acute renal failure during lisinopril and losartan therapy for proteinuria. Pharmacotherapy 26:1348\u20131351","journal-title":"Pharmacotherapy"},{"key":"721_CR118","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0140-6736(06)69172-1","volume":"368","author":"G Remuzzi","year":"2006","unstructured":"Remuzzi G, Ruggenenti P (2006) Overview of randomised trials of ACE inhibitors. Lancet 368:555\u2013556","journal-title":"Lancet"},{"key":"721_CR119","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/1-4020-2586-6_16","volume-title":"Clinical nephrotoxins","author":"PE de Jong","year":"2003","unstructured":"de Jong PE (2003) Angiotensin I converting enzyme inhibitors and angiotensin II receptor antagonists. In: deBroe ME, Porter GA, Bennett WM, Verpooten GA (eds) Clinical nephrotoxins, 2nd edn. Kluwer Academic, Dordrecht, pp 325\u2013338","edition":"2"},{"key":"721_CR120","first-page":"5","volume":"89","author":"EV Krishna","year":"1996","unstructured":"Krishna EV, Mehta AV, Subrahmanyam AB, Wattad AA (1996) Acute renal failure associated with use of angiotensin converting enzyme inhibitor\u2013a report of two children with Down syndrome. J Tenn Med Assoc 89:5\u20137","journal-title":"J Tenn Med Assoc"},{"key":"721_CR121","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/oxfordjournals.ndt.a091880","volume":"4","author":"T Ahmad","year":"1989","unstructured":"Ahmad T, Coulthard MG, Eastham EJ (1989) Reversible renal failure due to the use of captopril in a renal allograft recipient treated with cyclosporin. Nephrol Dial Transplant 4:311\u2013312","journal-title":"Nephrol Dial Transplant"},{"key":"721_CR122","first-page":"332","volume":"71","author":"J Wiggelinkhuizen","year":"1987","unstructured":"Wiggelinkhuizen J (1987) Reversible renal failure and captopril therapy in renovascular hypertension. S Afr Med J 71:332\u2013333","journal-title":"S Afr Med J"},{"key":"721_CR123","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/1-4020-2586-6_21","volume-title":"Clinical nephrotoxins","author":"AA Burdmann","year":"2003","unstructured":"Burdmann AA, Yu L, Andoh TF, Perico N, Bennett WM (2003) Calcineurin inhibitors and sirolimus. In: deBroe ME, Porter GA, Bennett WM, Verpooten GA (eds) Clinical nephrotoxins, 2nd edn. Kluwer Academic, Dordrecht , pp 403\u2013458","edition":"2"},{"key":"721_CR124","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/ki.1997.328","volume":"52","author":"DB Lee","year":"1997","unstructured":"Lee DB (1997) Cyclosporine and the renin-angiotensin axis. Kidney Int 52:248\u2013260","journal-title":"Kidney Int"},{"key":"721_CR125","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0272-6386(00)70348-9","volume":"35","author":"AM de Mattos","year":"2000","unstructured":"de Mattos AM, Olyaei AJ, Bennett WM (2000) Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future. Am J Kidney Dis 35:333\u2013346","journal-title":"Am J Kidney Dis"},{"key":"721_CR126","first-page":"SS18","volume":"69","author":"NC Fisher","year":"2000","unstructured":"Fisher NC, Malag M, Gonzlez-Pinto I (2000) The clinical impact of nephrotoxicity in liver transplantation. Transplantation 69:SS18\u2013SS22","journal-title":"Transplantation"},{"key":"721_CR127","doi-asserted-by":"crossref","first-page":"SS23","DOI":"10.1097\/00007890-200006271-00006","volume":"69","author":"G Parry","year":"2000","unstructured":"Parry G, Meiser B, Rabago G (2000) The clinical impact of cyclosporine nephrotoxicity in heart transplantation. Transplantation 69:SS23\u2013SS26","journal-title":"Transplantation"},{"key":"721_CR128","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1097\/00007890-200005270-00014","volume":"69","author":"M Tsimaratos","year":"2000","unstructured":"Tsimaratos M, Viard L, Kreitmann B, Remediani C, Picon G, Camboulives J, Sarles J, Metras D (2000) Kidney function in cyclosporine-treated paediatric pulmonary transplant recipients. Transplantation 69:2055\u20132059","journal-title":"Transplantation"},{"key":"721_CR129","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1093\/ndt\/13.10.2464","volume":"13","author":"C Noel","year":"1998","unstructured":"Noel C, Hazzan M, Noel-Walter MP, Jouet JP (1998) Renal failure and bone marrow transplantation. Nephrol Dial Transplant 13:2464\u20132466","journal-title":"Nephrol Dial Transplant"},{"key":"721_CR130","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/00075198-200112000-00003","volume":"7","author":"AJ Olyaei","year":"2001","unstructured":"Olyaei AJ, de Mattos AM, Bennett WM (2001) Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies. Curr Opin Crit Care 7:384\u2013389","journal-title":"Curr Opin Crit Care"},{"key":"721_CR131","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1681\/ASN.V111177","volume":"11","author":"SW Murphy","year":"2000","unstructured":"Murphy SW, Barrett BJ, Parfrey PS (2000) Contrast nephropathy. J Am Soc Nephrol 11:177\u2013182","journal-title":"J Am Soc Nephrol"},{"key":"721_CR132","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/ki.1995.32","volume":"47","author":"MR Rudnick","year":"1995","unstructured":"Rudnick MR, Goldfarb S, Wexler L, Ludbrook PA, Murphy MJ, Halpern EF, Hill JA, Winniford M, Cohen MB, VanFossen DB (1995) Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study. Kidney Int 47:254\u2013261","journal-title":"Kidney Int"},{"key":"721_CR133","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1148\/radiology.188.1.8511292","volume":"188","author":"BJ Barrett","year":"1993","unstructured":"Barrett BJ, Carlisle EJ (1993) Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology 188:171\u2013178","journal-title":"Radiology"},{"key":"721_CR134","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00041552-200411000-00011","volume":"13","author":"M Tepel","year":"2004","unstructured":"Tepel M, Zidek W (2004) N-Acetylcysteine in nephrology; contrast nephropathy and beyond. Curr Opin Nephrol Hypertens 13:649\u2013654","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"721_CR135","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/00041552-200209000-00005","volume":"11","author":"M Tepel","year":"2002","unstructured":"Tepel M, Zidek W (2002) Acetylcysteine and contrast media nephropathy. Curr Opin Nephrol Hypertens 11:503\u2013506","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"721_CR136","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/00075198-200112000-00004","volume":"7","author":"M Tepel","year":"2001","unstructured":"Tepel M, Zidek W (2001) Acetylcysteine for radiocontrast nephropathy. Curr Opin Crit Care 7:390\u2013392","journal-title":"Curr Opin Crit Care"},{"key":"721_CR137","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3949\/ccjm.73.1.75","volume":"73","author":"MR Rudnick","year":"2006","unstructured":"Rudnick MR, Kesselheim A, Goldfarb S (2006) Contrast-induced nephropathy: how it develops, how to prevent it. Cleve Clin J Med 73:75\u201377","journal-title":"Cleve Clin J Med"},{"key":"721_CR138","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00467-003-1146-9","volume":"18","author":"L Patzer","year":"2003","unstructured":"Patzer L, Kentouche K, Ringelmann F, Misselwitz J (2003) Renal function following hematological stem cell transplantation in childhood. Pediatr Nephrol 18:623\u2013635","journal-title":"Pediatr Nephrol"},{"key":"721_CR139","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/pbc.20858","volume":"48","author":"W Stohr","year":"2007","unstructured":"Stohr W, Paulides M, Bielack S, Jurgens H, Treuner J, Rossi R, Langer T, Beck JD (2007) Ifosfamide-induced nephrotoxicity in 593 sarcoma patients: a report from the Late Effects Surveillance System. Pediatr Blood Cancer 48:447\u2013452","journal-title":"Pediatr Blood Cancer"},{"key":"721_CR140","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s004670050585","volume":"13","author":"R Rossi","year":"1999","unstructured":"Rossi R, Kleta R, Ehrich JH (1999) Renal involvement in children with malignancies. Pediatr Nephrol 13:153\u2013162","journal-title":"Pediatr Nephrol"},{"key":"721_CR141","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1054\/bjoc.2000.1214","volume":"82","author":"R Skinner","year":"2000","unstructured":"Skinner R, Cotterill SJ, Stevens MC (2000) Risk factors for nephrotoxicity after ifosfamide treatment in children: a UKCCSG Late Effects Group study. United Kingdom Children\u2019s Cancer Study Group. Br J Cancer 82:1636\u20131645","journal-title":"Br J Cancer"},{"key":"721_CR142","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1038\/bjc.1998.276","volume":"77","author":"R Skinner","year":"1998","unstructured":"Skinner R, Pearson AD, English MW, Price L, Wyllie RA, Coulthard MG, Craft AW (1998) Cisplatin dose rate as a risk factor for nephrotoxicity in children. Br J Cancer 77:1677\u20131682","journal-title":"Br J Cancer"},{"key":"721_CR143","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1172\/JCI0216568","volume":"110","author":"RW Schrier","year":"2002","unstructured":"Schrier RW (2002) Cancer therapy and renal injury. J Clin Invest 110:743\u2013745","journal-title":"J Clin Invest"},{"key":"721_CR144","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2165\/00002018-200124010-00003","volume":"24","author":"PE Kintzel","year":"2001","unstructured":"Kintzel PE (2001) Anticancer drug-induced kidney disorders. Drug Saf 24:19\u201338","journal-title":"Drug Saf"},{"key":"721_CR145","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/cc4907","volume":"10","author":"M Darmon","year":"2006","unstructured":"Darmon M, Ciroldi M, Thiery G, Schlemmer B, Azoulay E (2006) Clinical review: specific aspects of acute renal failure in cancer patients. Crit Care 10:211","journal-title":"Crit Care"},{"key":"721_CR146","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/(SICI)1096-911X(199903)32:3<177::AID-MPO3>3.0.CO;2-H","volume":"32","author":"R Rossi","year":"1999","unstructured":"Rossi R, Pleyer J, Schafers P, Kuhn N, Kleta R, Deufel T, Jurgens H (1999) Development of ifosfamide-induced nephrotoxicity: prospective follow-up in 75 patients. Med Pediatr Oncol 32:177\u2013182","journal-title":"Med Pediatr Oncol"},{"key":"721_CR147","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1200\/JCO.1994.12.1.159","volume":"12","author":"R Rossi","year":"1994","unstructured":"Rossi R, Godde A, Kleinebrand A, Riepenhausen M, Boos J, Ritter J, Jurgens H (1994) Unilateral nephrectomy and cisplatin as risk factors of ifosfamide-induced nephrotoxicity: analysis of 120 patients. J Clin Oncol 12:159\u2013165","journal-title":"J Clin Oncol"},{"key":"721_CR148","first-page":"69","volume":"11","author":"RC Stuart-Harris","year":"1983","unstructured":"Stuart-Harris RC, Harper PG, Parsons CA, Kaye SB, Mooney CA, Gowing NF, Wiltshaw E (1983) High-dose alkylation therapy using ifosfamide infusion with mesna in the treatment of adult advanced soft-tissue sarcoma. Cancer Chemother Pharmacol 11:69\u201372","journal-title":"Cancer Chemother Pharmacol"},{"key":"721_CR149","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF00292414","volume":"23","author":"PH Willemse","year":"1989","unstructured":"Willemse PH, de Jong PE, Elema JD, Mulder NH (1989) Severe renal failure following high-dose ifosfamide and mesna. Cancer Chemother Pharmacol 23:329\u2013330","journal-title":"Cancer Chemother Pharmacol"},{"key":"721_CR150","first-page":"173","volume":"38","author":"L Patzer","year":"1999","unstructured":"Patzer L, Ringelmann F, Kentouche K, Zintl F, Misselwitz J (1999) Ungew\u00f6hnlicher Verlauf eines deToni-Debr\u00e8-Fanconi-Syndroms nach Ifosfamidtherapie. P\u00e4diatrie und Grenzgebiete 38:173\u2013183","journal-title":"P\u00e4diatrie und Grenzgebiete"},{"key":"721_CR151","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2605.1987.tb00200.x","volume":"10","author":"R Safirstein","year":"1987","unstructured":"Safirstein R, Winston J, Moel D, Dikman S, Guttenplan J (1987) Cisplatin nephrotoxicity: insights into mechanism. Int J Androl 10:325\u2013346","journal-title":"Int J Androl"},{"key":"721_CR152","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1111\/j.1523-1755.2004.09109.x","volume":"66","author":"G Ramesh","year":"2004","unstructured":"Ramesh G, Reeves WB (2004) Inflammatory cytokines in acute renal failure. Kidney Int Suppl 66:S56\u2013S61","journal-title":"Kidney Int Suppl"},{"key":"721_CR153","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00204-003-0521-4","volume":"78","author":"D Sheikh-Hamad","year":"2004","unstructured":"Sheikh-Hamad D, Cacini W, Buckley AR, Isaac J, Truong LD, Tsao CC, Kishore BK (2004) Cellular and molecular studies on cisplatin-induced apoptotic cell death in rat kidney. Arch Toxicol 78:147\u2013155","journal-title":"Arch Toxicol"},{"key":"721_CR154","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/0024-3205(83)90299-0","volume":"32","author":"RS Goldstein","year":"1983","unstructured":"Goldstein RS, Mayor GH (1983) Minireview. The nephrotoxicity of cisplatin. Life Sci 32:685\u2013690","journal-title":"Life Sci"},{"key":"721_CR155","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0022-3476(85)80098-6","volume":"106","author":"RB Womer","year":"1985","unstructured":"Womer RB, Pritchard J, Barratt TM (1985) Renal toxicity of cisplatin in children. J Pediatr 106:659\u2013663","journal-title":"J Pediatr"},{"key":"721_CR156","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/1-4020-2586-6_18","volume-title":"Clinical nephrotoxins","author":"C Isnard-Bagnis","year":"2003","unstructured":"Isnard-Bagnis C, Deray G (2003) Anticancer drugs. In: deBroe ME, Porter GA, Bennett WM, Verpooten GA (eds) Clinical nephrotoxins, 2nd edn. Kluwer Academic, Dordrecht, pp 353\u2013372","edition":"2"},{"key":"721_CR157","first-page":"31","volume":"66","author":"M Al Sarraf","year":"1982","unstructured":"Al Sarraf M, Fletcher W, Oishi N, Pugh R, Hewlett JS, Balducci L, McCracken J, Padilla F (1982) Cisplatin hydration with and without mannitol diuresis in refractory disseminated malignant melanoma: a Southwest Oncology Group study. Cancer Treat Rep 66:31\u201335","journal-title":"Cancer Treat Rep"},{"key":"721_CR158","first-page":"589","volume":"13","author":"GP Stathopoulos","year":"2005","unstructured":"Stathopoulos GP, Boulikas T, Vougiouka M, Deliconstantinos G, Rigatos S, Darli E, Viliotou V, Stathopoulos JG (2005) Pharmacokinetics and adverse reactions of a new liposomal cisplatin (Lipoplatin): phase I study. Oncol Rep 13:589\u2013595","journal-title":"Oncol Rep"},{"key":"721_CR159","first-page":"2193","volume":"24","author":"P Devarajan","year":"2004","unstructured":"Devarajan P, Tarabishi R, Mishra J, Ma Q, Kourvetaris A, Vougiouka M, Boulikas T (2004) Low renal toxicity of lipoplatin compared to cisplatin in animals. Anticancer Res 24:2193\u20132200","journal-title":"Anticancer Res"},{"key":"721_CR160","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1634\/theoncologist.11-6-694","volume":"11","author":"BC Widemann","year":"2006","unstructured":"Widemann BC, Adamson PC (2006) Understanding and managing methotrexate nephrotoxicity. Oncologist 11:694\u2013703","journal-title":"Oncologist"},{"key":"721_CR161","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1523-1755.2005.00078.x","volume":"67","author":"SR Hingorani","year":"2005","unstructured":"Hingorani SR, Guthrie K, Batchelder A, Schoch G, Aboulhosn N, Manchion J, McDonald GB (2005) Acute renal failure after myeloablative hematopoietic cell transplant: incidence and risk factors. Kidney Int 67:272\u2013277","journal-title":"Kidney Int"},{"key":"721_CR162","doi-asserted-by":"crossref","first-page":"F546","DOI":"10.1152\/ajprenal.00072.2006","volume":"291","author":"RA Zager","year":"2006","unstructured":"Zager RA, Johnson AC, Lund S, Hanson S (2006) Acute renal failure: determinants and characteristics of the injury-induced hyperinflammatory response. Am J Physiol Renal Physiol 291:F546\u2013F556","journal-title":"Am J Physiol Renal Physiol"},{"key":"721_CR163","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1046\/j.1523-1755.2003.00071.x","volume":"64","author":"GS Markowitz","year":"2003","unstructured":"Markowitz GS, Fine PL, Stack JI, Kunis CL, Radhakrishnan J, Palecki W, Park J, Nasr SH, Hoh S, Siegel DS, D\u2019Agati VD (2003) Toxic acute tubular necrosis following treatment with zoledronate (Zometa). Kidney Int 64:281\u2013289","journal-title":"Kidney Int"},{"key":"721_CR164","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1136\/adc.2006.093997","volume":"91","author":"J Thornton","year":"2006","unstructured":"Thornton J, Ashcroft DM, Mughal MZ, Elliott RA, O\u2019Neill TW, Symmons D (2006) Systematic review of effectiveness of bisphosphonates in treatment of low bone mineral density and fragility fractures in juvenile idiopathic arthritis. Arch Dis Child 91:753\u2013761","journal-title":"Arch Dis Child"},{"key":"721_CR165","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1007\/s10067-007-0694-y","volume":"11","author":"F Tufan","year":"2007","unstructured":"Tufan F, Kamali S, Erer B, Gul A, Inanc M, Ocal L, Konice M, Aral O (2007) Safety of high-dose intravenous immunoglobulin in systemic autoimmune diseases. Clin Rheumatol 11:1913\u20131915","journal-title":"Clin Rheumatol"},{"key":"721_CR166","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.autrev.2006.08.011","volume":"6","author":"U Katz","year":"2007","unstructured":"Katz U, Achiron A, Sherer Y, Shoenfeld Y (2007) Safety of intravenous immunoglobulin (IVIG) therapy. Autoimmun Rev 6:257\u2013259","journal-title":"Autoimmun Rev"},{"key":"721_CR167","doi-asserted-by":"crossref","first-page":"c143","DOI":"10.1159\/000104424","volume":"106","author":"E Daphnis","year":"2007","unstructured":"Daphnis E, Stylianou K, Alexandrakis M, Xylouri I, Vardaki E, Stratigis S, Kyriazis J (2007) Acute renal failure, translocational hyponatremia and hyperkalemia following intravenous immunoglobulin therapy. Nephron Clin Pract 106:c143\u2013c148","journal-title":"Nephron Clin Pract"},{"key":"721_CR168","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1399-3046.2005.00379.x","volume":"9","author":"MM Subtirelu","year":"2005","unstructured":"Subtirelu MM, Flynn JT, Schechner RS, Pullman JM, Feuerstein D, Del Rio M (2005) Acute renal failure in a pediatric kidney allograft recipient treated with intravenous immunoglobulin for parvovirus B19 induced pure red cell aplasia. Pediatr Transplant 9:801\u2013804","journal-title":"Pediatr Transplant"},{"key":"721_CR169","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/1-4020-2586-6_31","volume-title":"Clinical nephrotoxins","author":"C Swanepoel","year":"2003","unstructured":"Swanepoel C, Naicker S, Moosa R, Katz I, Suleiman SM, Twahir M (2003) nephrotoxins in Africa. In: deBroe ME, Porter GA, Bennett WM, Verpooten GA (eds) Clinical nephrotoxins, 2nd edn. Kluwer Academic, Dordrecht, pp 603\u2013611","edition":"2"},{"key":"721_CR170","first-page":"427","volume":"54","author":"YK Seedat","year":"1978","unstructured":"Seedat YK (1978) Acute renal failure among Blacks and Indians in South Africa. S Afr Med J 54:427\u2013431","journal-title":"S Afr Med J"},{"key":"721_CR171","first-page":"220","volume-title":"Acute renal failure: a companion to Brenner and Rector\u2019s the kidney","author":"JP Knochel","year":"2001","unstructured":"Knochel JP (2001) Nontraumatic rhabdomyolysis. In: Molitoris BA, Finn WF (eds) Acute renal failure: a companion to Brenner and Rector\u2019s the kidney. WB Saunders, Philadelphia, pp 220\u2013226"},{"key":"721_CR172","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1097\/00003246-200108000-00005","volume":"29","author":"JA Kellum","year":"2001","unstructured":"Kellum JA, Decker M (2001) Use of dopamine in acute renal failure: a meta-analysis. Crit Care Med 29:1526\u20131531","journal-title":"Crit Care Med"},{"key":"721_CR173","first-page":"57","volume":"75","author":"MC Abay","year":"2007","unstructured":"Abay MC, Reyes JD, Everts K, Wisser J (2007) Current literature questions the routine use of low-dose dopamine. AANA J 75:57\u201363","journal-title":"AANA J"},{"key":"721_CR174","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.cursur.2005.08.008","volume":"63","author":"PJ Schenarts","year":"2006","unstructured":"Schenarts PJ, Sagraves SG, Bard MR, Toschlog EA, Goettler CE, Newell MA, Rotondo MF (2006) Low-dose dopamine: a physiologically based review. Curr Surg 63:219\u2013225","journal-title":"Curr Surg"},{"key":"721_CR175","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.annfar.2007.03.018","volume":"26","author":"F Leclerc","year":"2007","unstructured":"Leclerc F, Sadik A (2007) Is there still a place for dopamine in the paediatric critical care setting? Ann Fr Anesth Reanim 26:576\u2013580","journal-title":"Ann Fr Anesth Reanim"},{"key":"721_CR176","doi-asserted-by":"crossref","unstructured":"Barrington K, Brion LP (2002) Dopamine versus no treatment to prevent renal dysfunction in indomethacin-treated preterm newborn infants. Cochrane Database Syst Rev CD003213","DOI":"10.1002\/14651858.CD003213"},{"key":"721_CR177","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/cc103","volume":"1","author":"JA Kellum","year":"1997","unstructured":"Kellum JA (1997) The use of diuretics and dopamine in acute renal failure: a systematic review of the evidence. Crit Care 1:53\u201359","journal-title":"Crit Care"},{"key":"721_CR178","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1053\/j.ajkd.2004.04.001","volume":"44","author":"A Asif","year":"2004","unstructured":"Asif A, Epstein M (2004) Prevention of radiocontrast-induced nephropathy. Am J Kidney Dis 44:12\u201324","journal-title":"Am J Kidney Dis"},{"key":"721_CR179","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/01.ccx.0000144940.32521.de","volume":"10","author":"GM Barletta","year":"2004","unstructured":"Barletta GM, Bunchman TE (2004) Acute renal failure in children and infants. Curr Opin Crit Care 10:499\u2013504","journal-title":"Curr Opin Crit Care"},{"key":"721_CR180","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.mop.0000152995.81317.ae","volume":"17","author":"A Quan","year":"2005","unstructured":"Quan A, Quigley R (2005) Renal replacement therapy and acute renal failure. Curr Opin Pediatr 17:205\u2013209","journal-title":"Curr Opin Pediatr"},{"key":"721_CR181","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/01.mop.0000163357.58651.d5","volume":"17","author":"KR Bock","year":"2005","unstructured":"Bock KR (2005) Renal replacement therapy in pediatric critical care medicine. Curr Opin Pediatr 17:368\u2013371","journal-title":"Curr Opin Pediatr"},{"key":"721_CR182","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1177\/089686080102100410","volume":"21","author":"JT Flynn","year":"2001","unstructured":"Flynn JT, Kershaw DB, Smoyer WE, Brophy PD, McBryde KD, Bunchman TE (2001) Peritoneal dialysis for management of pediatric acute renal failure. Perit Dial Int 21:390\u2013394","journal-title":"Perit Dial Int"},{"key":"721_CR183","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1016\/S0272-6386(97)90547-3","volume":"30","author":"NJ Maxvold","year":"1997","unstructured":"Maxvold NJ, Smoyer WE, Gardner JJ, Bunchman TE (1997) Management of acute renal failure in the pediatric patient: hemofiltration versus hemodialysis. Am J Kidney Dis 30:S84\u2013S88","journal-title":"Am J Kidney Dis"},{"key":"721_CR184","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00467-003-1342-7","volume":"19","author":"V Strazdins","year":"2004","unstructured":"Strazdins V, Watson AR, Harvey B (2004) Renal replacement therapy for acute renal failure in children: European guidelines. Pediatr Nephrol 19:199\u2013207","journal-title":"Pediatr Nephrol"},{"key":"721_CR185","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/sj.ki.5000032","volume":"69","author":"DJ Askenazi","year":"2006","unstructured":"Askenazi DJ, Feig DI, Graham NM, Hui-Stickle S, Goldstein SL (2006) 3\u20135\u00a0year longitudinal follow-up of pediatric patients after acute renal failure. Kidney Int 69:184\u2013189","journal-title":"Kidney Int"},{"key":"721_CR186","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1111\/j.1523-1755.2005.09425.x","volume":"94","author":"WL Henrich","year":"2005","unstructured":"Henrich WL (2005) Nephrotoxicity of several newer agents. Kidney Int Suppl 94:S107-S109","journal-title":"Kidney Int Suppl"},{"key":"721_CR187","first-page":"1331","volume-title":"Diseases of the kidney","author":"JP Grunfeld","year":"1993","unstructured":"Grunfeld JP, Kleinknecht D, Droz D (1993) Acute interstitial nephritis. In: Schrier RW, Gottschalk CW (eds) Diseases of the kidney, 5th edn. Little Brown, Boston, pp 1331\u20131353","edition":"5"},{"key":"721_CR188","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0272-6386(89)80054-X","volume":"13","author":"RA Zager","year":"1989","unstructured":"Zager RA, O\u2019Quigley J, Zager BK, Alpers CE, Shulman HM, Gamelin LM, Stewart P, Thomas ED (1989) Acute renal failure following bone marrow transplantation: a retrospective study of 272 patients. Am J Kidney Dis 13:210\u2013216","journal-title":"Am J Kidney Dis"},{"key":"721_CR189","first-page":"613","volume":"13","author":"PH Lane","year":"1994","unstructured":"Lane PH, Mauer SM, Blazar BR, Ramsay NK, Kashtan CE (1994) Outcome of dialysis for acute renal failure in pediatric bone marrow transplant patients. Bone Marrow Transplant 13:613\u2013617","journal-title":"Bone Marrow Transplant"},{"key":"721_CR190","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/sj.bmt.1702763","volume":"27","author":"L Patzer","year":"2001","unstructured":"Patzer L, Ringelmann F, Kentouche K, Fuchs D, Zintl F, Brandis M, Zimmerhackl LB, Misselwitz J (2001) Renal function in long-term survivors of stem cell transplantation in childhood. A prospective trial. Bone Marrow Transplant 27:319\u2013327","journal-title":"Bone Marrow Transplant"},{"key":"721_CR191","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/sj.bmt.1705110","volume":"36","author":"JE Kist-van Holthe","year":"2005","unstructured":"Kist-van Holthe JE, Bresters D, Ahmed-Ousenkova YM, Goedvolk CA, Abbink FC, Wolterbeek R, Bredius RG, Pauwels EK, van der Heijden AJ (2005) Long-term renal function after hemopoietic stem cell transplantation in children. Bone Marrow Transplant 36:605\u2013610","journal-title":"Bone Marrow Transplant"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-007-0721-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-007-0721-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-007-0721-x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-007-0721-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T20:37:05Z","timestamp":1630615025000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-007-0721-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":191,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["721"],"URL":"https:\/\/doi.org\/10.1007\/s00467-007-0721-x","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12]]},"assertion":[{"value":"15 August 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2007","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2007","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2008","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}